Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

BACKGROUND: Recently, maintaining higher relative dose intensity (RDI) of chemotherapeutic drugs has become a widespread practice in an attempt to achieve better outcomes in the treatment of aggressive lymphoma. The addition of rituximab to chemotherapy regimens has significantly improved outcome in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Terada, Yoshiki, Nakamae, Hirohisa, Aimoto, Ran, Kanashima, Hiroshi, Sakamoto, Erina, Aimoto, Mizuki, Inoue, Eri, Koh, Hideo, Nakane, Takahiko, Takeoka, Yasunobu, Ohsawa, Masahiko, Koh, Ki-Ryang, Yamane, Takahisa, Nakao, Yoshitaka, Ohta, Kensuke, Mugitani, Atsuko, Teshima, Hirofumi, Hino, Masayuki
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743657/
https://ncbi.nlm.nih.gov/pubmed/19689822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados